Same here. I'll have funds available for unrestricted trading this coming Friday. I hope to get some of those 2s if they're still around then to lower my cost basis.
In my opinion VIBI is oversold. One should expect VIBI's share price to drop as dilution increases to keep market cap in check. But the extremely low market cap suggests to me that investors have given up all hope of Vilacto Bio as ever making it out of the woods.
Their patent has real value. If they can't capitalize on it because of lack of funding, then perhaps a biotech with deeper pockets can. Any news of Vilacto Bio being bought out could send VIBI's SP into the stratosphere literally overnight. It's why I'm still a buyer here.
Lots of risks for sure. But with higher risk also comes potential for higher rewards :-)
News 
Market Data 
Discover 
